DW-3101

· Daewon Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DW-3101, covering 2016-10-12 to 2016-10-12. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2a Study to Evaluate Optimum Dosage and Stability of DW-3101 in Gastric Inflammation Patients [Phase 2]